8X8 INC /DE/ financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data 8X8 INC /DE/ files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Revenue	253	297	353	446	532	638	744	729	715	736
Cost of revenue	19.7	20.5				248	241	225	230	261
Gross profit	234	276				391	502	504	485	475
Research and development	29	36.4	62.1	77.8	92	112	142	136	123	113
Selling and marketing	98.9	134	178	240	256	314	312	272	264	252
General and administrative	41.9	51.9	72.2	87	100	118	108	112	82.4	90.7
Operating expenses	260	338	442	606	678	545	569	531	470	456
Operating income	-6.67	-41.9	-89.6	-160	-146	-154	-66.3	-27.6	15.2	18.9
Interest expense							27.3	39.8	28.9	17.8
Other non-operating income	1.79	3.69	1.46	-11.7	-18.6	-21.6	23.2	3.48	-10.4	2.35
Pre-tax income	-4.88	-38.2	-88.2	-172	-165	-176	-70.3	-64	-24.1	3.53
Income tax	-0.13	66.3	0.57	0.83	0.84	-0.39	2.81	3.64	3.15	1.88
Net income	-4.75	-104	-88.7	-172	-166	-175	-73.1	-67.6	-27.2	1.65
EBITDA	3.77	-31.2	-71.1	-131	-107	-112	-29.5	-0.8	35.3	37
EPS, basic	-0.05	-1.14	-0.94	-1.72	-1.57	-1.55	-0.63	-0.56	-0.21	0.01
EPS, diluted	-0.05	-1.14	-0.94	-1.72	-1.57	-1.55	-0.63	-0.56	-0.21	0.01
Shares, basic (weighted)	90.3	92	94.5	100	106	113	116	121	130	138
Shares, diluted (weighted)	90.3	92	94.5	100	106	113	116	121	130	143

Balance sheet

	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Cash and equivalents	41	31.7	277	137	113	91.2	111	116	88.1	93.3
Short-term investments	134	121	69.9	33.5	40.3	44.8	26.2	1.05	0
Receivables	14.3	16.3	20.2	37.8	51.2	57.4	62.3	59	49.7	57
Inventory	0.91
Other current assets	8.1	10	15.1	35.7	34.1	38	34.6	35.3	34.7	32.7
Total current assets	197	179	397	277	277	276	273	248	204	210
Property, plant and equipment	24.1	35.7	52.8	94.4	93.1	79	57.9	53.2	47.9	45.8
Lease right-of-use assets				79	66.7	63.4	52.4	35.9	33.5	26.7
Goodwill	46.1	40.1	39.7	128	132	267	267	267	272	276
Intangible assets	17	12	11.7	24	17.1	128	107	86.7	67.9	57.6
Long-term investments			0	16.1	0	2.67	0
Other non-current assets	0.41	2.77	2.97	19.8	20.6	18	15.9	12.8	13.4	12
Total assets	334	277	546	701	678	910	842	756	683	663
Accounts payable	18.6	23.9	32.3	40.3	31.2	49.7	46.8	48.9	45.8	36.7
Accrued liabilities	11.5	17.4	18.4	22.7	29.9	36.3	73.7	78.1	63	69.9
Deferred revenue	2.14	2.56	3.34	7.11	20.7	34.3	34.9	34.3	37.8	36.7
Short-term debt								0	11.6	39.2
Total current liabilities	43.3	56.3	74.7	123	121	192	230	173	169	193
Long-term debt		0	216	292	308	447		410	338	282
Lease liabilities				92.5	82.5	74.5	65.6	56.6	49.2	39.1
Other non-current liabilities	1.85	2.15	6.23	2.5	2.64	2.98	6.97	7.29	3.46	1.82
Total liabilities	45.3	58.4	297	510	518	728	742	654	561	516
Total debt		0	216	292	308	447		410	350	321
Paid-in capital	413	426	507	625	756	957	906	974	1,019	1,039
Retained earnings	-115	-201	-250	-423	-591	-766	-793	-861	-888	-886
Other comprehensive income	-9.64	-5.65	-7.35	-12.2	-4.19	-7.91	-12.9	-11.6	-9.11	-6.2
Shareholders' equity	289	219	249	191	161	182	99.9	102	122	147
Total equity	289	219	249	191	161	182	99.9	102	122	147
Total liabilities and equity	334	277	546	701	678	910	842	756	683	663
Shares outstanding	91.5	92.8	96.1	103	109	118	115	125	134	141

Cash flow statement

	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Net income	-4.75	-104	-88.7	-172	-166	-175	-73.1	-67.6	-27.2	1.65
Depreciation and amortization	10.4	10.7	18.5	28.4	39	42.1	36.8	26.8	20.1	18.1
Stock-based compensation	21.5	29.2	44.5	70.9	108	133	89.5	61.9	39.9	20.4
Deferred income tax	-0.41	66.3	0	0	0	-1.25	0	0
Change in receivables	-4.8	-2.4	-5.39	-12.7	-14.9	6.87	-8.45	0.75	7.85	-5.77
Change in inventory	-0.43
Change in payables	4.17	11.9	17.3	2.16	-10	-8.74	-24.4	-4.18	-24.8	-17.4
Cash from operations	28.5	22	-14.9	-93.9	-14.1	34.7	48.8	79	63.6	55.8
Capital expenditures	-8.85	-9.18	-9.1	-35.8	-6.43	-4.14	-2.99	-2.65	-2.4	-3.68
Acquisitions	-2.88	0	-5.63	-59.1	-10.4	-125	-1.25	0	-3.23	-4.76
Purchases of investments	-140	-115	-54.1	-42.2	-52.2	-83.4	-53.3	-6.17	0	0
Sales and maturities of investments	41.3	27.8	54.6	36.5	1.02	13.3	8.3	0	0
Cash from investing	-22.2	-7.27	10.9	-106	-36.3	-160	6.05	8.55	-16.4	-20.7
Debt issued						0	235	0	200	0
Share buybacks	-3	-22.4	-7.82	0	0	-45	-60.2	0	0	-1.85
Cash from financing	1.6	-16.4	249	72.1	13.2	105	-37.8	-83.4	-75.1	-30.4
Exchange rate effect	-0.43	0.44	-0.36	-0.17	1.96	-0.59	-5.04	-0.13	0.58	1.03
Net change in cash	7.45	-1.23	245	-128	-35.2	-20.5	12	3.99	-27.4	5.64
Free cash flow	19.6	12.9	-24	-130	-20.5	30.5	45.8	76.3	61.2	52.1
Interest paid	0.02	0.04	0	1.55	1.81	2.16	22.2	35.6	26.3	17.3
Income taxes paid	0.46	0.04	0.36	0.93	0.56	1.32	1.53	6	3.8	2.4

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $2.30 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	63.3%	Gross profit / revenue.
Operating margin	3.1%	Operating income / revenue.
EBITDA margin	3.9%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	0.9%	Pre-tax income / revenue.
Net margin	0.6%	Net income / revenue.
FCF margin	7.6%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	8.2%	Cash from operations / revenue.
Effective tax rate	25.1%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	3.2%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	0.7%	Net income / average total assets.
Return on invested capital (ROIC)	4.7%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue	15.2%	Research and development expense / revenue.
Stock-based pay / revenue	2.4%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	0.5%	Capital expenditures / revenue.
D&A / revenue	0.9%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	2.9%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	-0.4%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	6.7%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	-2.1%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	-1.9%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income growth, 1y	24.6%	Operating income vs the same period a year earlier. Only from a positive base.
EBITDA growth, 1y	4.9%	EBITDA vs the same period a year earlier. Only from a positive base.
Operating cash flow growth, 1y	-12.2%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	4.6%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow growth, 1y	-14.8%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y	4.4%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value growth, 1y	20.0%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	13.6%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	-1.8%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	-3.0%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	-7.7%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	-0.5%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	9.9%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	7.1%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	6.2%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	1.05x	Current assets / current liabilities.
Quick ratio	0.75x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.42x	(Cash + short-term investments) / current liabilities.
Debt / equity	2.08x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	45.7%	Total debt / total assets.
Liabilities / assets	78.0%	Total liabilities / total assets.
Net debt	$216.8M	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	7.45x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage	1.27x	Operating income / interest expense.
Working capital	$10.2M	Current assets - current liabilities.
Goodwill and intangibles / assets	49.1%	(Goodwill + intangible assets) / total assets.
Tangible book value	-$182.4M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	1.11x	Revenue / average total assets.
Fixed asset turnover	16.7x	Revenue / average property, plant and equipment.
Receivables turnover	10.6x	Revenue / average receivables.
Days sales outstanding	35 days	365 x average receivables / revenue.
Days payables	51 days	365 x average accounts payable / cost of revenue.
FCF conversion	1,196.0%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	6.5%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$0.03	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$5.24	Revenue / diluted weighted shares.
FCF per share	$0.40	Free cash flow / diluted weighted shares.
Operating cash flow per share	$0.43	Cash from operations / diluted weighted shares.
Book value per share	$1.03	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	-$1.27	Tangible book value / shares outstanding.
Cash per share	$0.63	(Cash + short-term investments) / shares outstanding.
Buybacks / FCF	0.0%	Share buybacks / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$332.2M	Share price x shares outstanding.
Enterprise value	$549.0M	Market cap + total debt - cash - short-term investments.
P/E	69.7x	Market cap / net income. Only when net income is positive.
P/S	0.45x	Market cap / revenue.
P/B	2.25x	Market cap / shareholders' equity. Only when equity is positive.
P/FCF	5.83x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	5.45x	Market cap / cash from operations, when positive.
EV/Sales	0.74x	Enterprise value / revenue.
EV/EBIT	24.1x	Enterprise value / operating income, when both are positive.
EV/EBITDA	18.9x	Enterprise value / EBITDA, when both are positive.
EV/FCF	9.64x	Enterprise value / free cash flow, when both are positive.
FCF yield	17.1%	Free cash flow / market cap.
Earnings yield	1.4%	Net income / market cap (the inverse of P/E).
Shareholder yield	0.0%	(Dividends paid + share buybacks) / market cap.

What was 8X8 INC /DE/'s revenue in fiscal 2026?

8X8 INC /DE/ reported revenue of $735.8M for fiscal 2026, 2.9% higher than the year before.

Was 8X8 INC /DE/ profitable in fiscal 2026?

Yes. Net income was $1.6M, a net margin of 0.2%.

How much free cash flow did 8X8 INC /DE/ generate in fiscal 2026?

Cash from operations of $55.8M minus capital expenditures of $3.7M left free cash flow of $52.1M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to 8X8 INC /DE/